2025
A multicenter cross-sectional study of gambling disorder among patients with methamphetamine use disorder in drug rehabilitation centers: prevalence, correlates, and network analysis
Peng P, Hao Y, Zhang X, Ma Y, Liu X, Shen D, Shen W, Zhao B, Li D, Beck S, Nunez Y, Potenza M, Gelernter J, Liu T, Yang B. A multicenter cross-sectional study of gambling disorder among patients with methamphetamine use disorder in drug rehabilitation centers: prevalence, correlates, and network analysis. Annals Of General Psychiatry 2025, 24: 12. PMID: 40033412, PMCID: PMC11877697, DOI: 10.1186/s12991-025-00546-0.Peer-Reviewed Original ResearchSemi-Structured Assessment for Drug Dependence and AlcoholismDSM-5 diagnostic criteriaGambling disorderDSM-5Antisocial personality disorderMethamphetamine use disorderSubstance use disordersDiagnostic criteriaPersonality disorderBridge symptomsDepressive episodeDrug rehabilitation centersCentral symptomsPsychiatric diagnosisGambling durationUse disorderSelf-harmChildhood experiencesMethamphetamineAlcohol useViolent experiencesDisordersManifest symptomsChinese versionMDEChikungunya Fever and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
Amaral J, Schoen R, Weinblatt M, Cândido E. Chikungunya Fever and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. Tropical Medicine And Infectious Disease 2025, 10: 54. PMID: 39998058, PMCID: PMC11861052, DOI: 10.3390/tropicalmed10020054.Peer-Reviewed Original ResearchChikungunya virus infectionRheumatoid arthritisChikungunya virusChikungunya feverChronic chikungunya arthritisRheumatology follow-upIncidence of RARisk of biasChikungunya arthritisAutoimmune mechanismsImmunological mechanismsFollow-upRA incidenceRA diagnosisDiagnostic criteriaRA developmentInfectionPRISMA guidelinesRe-emerging infectious diseasesLiterature searchDiagnostic biomarkersLong-term health impactsData extractionInfectious diseasesIncidenceIncidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study
Vernon S, Zheng T, Do H, Marconi V, Jason L, Singer N, Natelson B, Sherif Z, Bonilla H, Taylor E, Mullington J, Ashktorab H, Laiyemo A, Brim H, Patterson T, Akintonwa T, Sekar A, Peluso M, Maniar N, Bateman L, Horwitz L, Hess R. Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study. Journal Of General Internal Medicine 2025, 1-10. PMID: 39804551, DOI: 10.1007/s11606-024-09290-9.Peer-Reviewed Original ResearchSARS-CoV-2 infectionLongitudinal observational cohort studyClinical diagnostic criteriaSelf-reported symptomsResultsThe incidence rateBackgroundMyalgic encephalomyelitis/chronic fatigue syndromeTiming of SARS-CoV-2 infectionPost-exertional malaiseObservational cohort studyUninfected participantsPost-acuteSARS-CoV-2Diagnostic criteriaCohort studyHazard ratioStudy visitsFatigue syndromeParticipantsEnhanced recoveryME/CFS symptomsLong COVIDMyalgic encephalomyelitisDays of infectionPrevalenceInfected participants
2024
MDMA and MDMA-Assisted Therapy
Wolfgang A, Fonzo G, Gray J, Krystal J, Grzenda A, Widge A, Kraguljac N, McDonald W, Rodriguez C, Nemeroff C. MDMA and MDMA-Assisted Therapy. American Journal Of Psychiatry 2024, 182: 79-103. PMID: 39741438, DOI: 10.1176/appi.ajp.20230681.Peer-Reviewed Original ResearchConceptsMDMA-assisted therapyPosttraumatic stress disorderControlled clinical settingRecreational useMDMA administrationNeurobiological mechanismsStress disorderEgo functionsSelf-compassionMDMAEfficacious treatmentPreliminary evidenceHeightened trustTherapeutic settingNonclinical settingsDiagnostic criteriaFood and Drug AdministrationBreakthrough therapiesClinical settingNonmedical settingsConsiderable bodyPsychotherapyPsychedelicsLong-term follow-upDrug AdministrationRenovascular hypertension – a primer for the radiologist
Dixe de Oliveira Santo I, Sindoni J, Czeyda-Pommersheim F, Solomon N, Sailer A, Bhatt S, Fananapazir G, Pellerito J, Revzin M. Renovascular hypertension – a primer for the radiologist. Abdominal Radiology 2024, 1-13. PMID: 39542950, DOI: 10.1007/s00261-024-04677-y.Peer-Reviewed Original ResearchRenovascular hypertensionRenal arteryCause of renovascular hypertensionComputed tomography angiographyMagnetic resonance angiographyDiagnosing RVHExtrinsic compressionSecondary hypertensionRare conditionImaging findingsPolyarteritis nodosaSurgical interventionFibromuscular dysplasiaAnatomical variantsPage kidneyPictorial reviewHypertension casesAccurate diagnosisMedical managementDiagnostic criteriaTreatment approachesImaging modalitiesHypertensionImpact diagnosisYoung femalesUnveiling the Structure in Mental Disorder Presentations
Spiller T, Duek O, Helmer M, Murray J, Fielstein E, Pietrzak R, von Känel R, Harpaz-Rotem I. Unveiling the Structure in Mental Disorder Presentations. JAMA Psychiatry 2024, 81: 1101-1107. PMID: 39110437, PMCID: PMC11307158, DOI: 10.1001/jamapsychiatry.2024.2047.Peer-Reviewed Original ResearchSymptom combinationsNational Institute of Mental Health Data ArchivePosttraumatic stress disorderDiagnostic criteriaHeterogeneity of symptomsSecondary data analysisCross-sectional studyRevision of diagnostic criteriaSymptom-based definitionsDSM criteriaStress disorderSymptom heterogeneityDisorder presentationsClinical populationsMain OutcomesAssess symptomsGroup of individualsParticipantsSymptomsNational InstituteDisordersIndividualsSchizophreniaAnxietyIndividual frequenciesMisdiagnosis of Multiple Sclerosis: Past, Present, and Future
Rjeily N, Solomon A. Misdiagnosis of Multiple Sclerosis: Past, Present, and Future. Current Neurology And Neuroscience Reports 2024, 24: 547-557. PMID: 39243340, DOI: 10.1007/s11910-024-01371-w.Peer-Reviewed Original ResearchMS diagnostic criteriaMultiple sclerosisDiagnostic criteriaCentral vein signParamagnetic rim lesionsAssociated with misdiagnosisRecent FindingsRecent studiesMS misdiagnosisMRI findingsEvaluating patientsSuspected MSDiagnostic accuracyRim lesionsFindingsRecent studiesImaging biomarkersMisdiagnosisDiagnostic biomarkersCommon disordersPatientsBiomarkersPotential strategyOpioid and Substance Use Disorders
Gonzalez-Fiol A, Fardelmann K. Opioid and Substance Use Disorders. 2024, 323-333. DOI: 10.1007/978-3-031-62756-9_40.Peer-Reviewed Original ResearchSubstance use disordersUse disorderDSM-5 diagnostic criteriaTreating substance use disordersPregnant patientsDSM-5National Survey on Drug Use and HealthDrug Use and HealthPatterns of behaviorImpaired controlReferral to treatmentSedative hypnoticsBrief interventionDisordersFetal outcomesFetal morbidityDiagnostic criteriaIllicit drugsPregnant womenEvidence-based approachHealthcare providersPathological patternsTobacco productsSocial stigmaSocioeconomic demographicsAssociation patterns of antisocial personality disorder across substance use disorders
Low A, Stiltner B, Nunez Y, Adhikari K, Deak J, Pietrzak R, Kranzler H, Gelernter J, Polimanti R. Association patterns of antisocial personality disorder across substance use disorders. Translational Psychiatry 2024, 14: 346. PMID: 39198385, PMCID: PMC11358160, DOI: 10.1038/s41398-024-03054-z.Peer-Reviewed Original ResearchConceptsAntisocial personality disorderSubstance use disordersPersonality disorderUse disorderAssociation of antisocial personality disorderPresence of antisocial personality disorderPrevalence of antisocial personality disorderHazardous useDSM-5 SUD diagnosesSubstance use disorder severityDiagnostic criteriaInteraction effects with sexTobacco use disorderDSM-5Association of alcoholSUD diagnosisDisordersCocaineRacial/ethnic backgroundsIndividualsCocUDSeverityCannabisAssociation patternsAssociationEvaluation and Management of Biliary Dyskinesia in Children and Adolescents: A Systematic Review From the APSA Outcomes and Evidence-Based Committee
Kulaylat A, Lucas D, Chang H, Derderian S, Beres A, Ham P, Huerta C, Sulkowski J, Wakeman D, Englum B, Gulack B, Acker S, Gonzalez K, Levene T, Christison-Lagay E, Mansfield S, Yousef Y, Pennell C, Russell K, Rentea R, Tashiro J, Diesen D, Alemayehu H, Ricca R, Kelley-Quon L, Rialon K. Evaluation and Management of Biliary Dyskinesia in Children and Adolescents: A Systematic Review From the APSA Outcomes and Evidence-Based Committee. Journal Of Pediatric Surgery 2024, 59: 161678. PMID: 39227244, DOI: 10.1016/j.jpedsurg.2024.08.018.Peer-Reviewed Original ResearchSystematic reviewBiliary dyskinesiaOxford Levels of EvidencePreferred Reporting ItemsGrading of RecommendationsAmerican Pediatric Surgical Association OutcomesRisk of biasEvidence-based recommendationsDiagnostic criteriaPredictors of symptom reliefLevel of evidenceNon-operative managementResolution of symptomsPediatric-specific guidelinesOutcome of medical managementLong-term outcomesReporting ItemsNon-randomized studiesOxford LevelsMeta-analysesMethodological IndexAssociated outcomesClinical entityProspective studySymptom reliefFrom criteria to clinic: How updated SLiM CRAB criteria influence multiple myeloma diagnostic activity.
Ji M, Wang M, Shih Y, Huber J, Fiala M, Wang R, Sanfilippo K, Thomas T, Wang S, Schoen M, Chang S. From criteria to clinic: How updated SLiM CRAB criteria influence multiple myeloma diagnostic activity. Journal Of Clinical Oncology 2024, 42: 7556-7556. DOI: 10.1200/jco.2024.42.16_suppl.7556.Peer-Reviewed Original ResearchInternational Myeloma Working GroupMagnetic resonance imagingFree light chainsMGUS patientsMM casesActive MMDiagnostic criteriaMultiple myelomaPlasma cellsClonal bone marrow plasma cellsComputed tomographyOld criteriaPositron emission tomography-CTBone marrow plasma cellsSerum free light chainsSLiM-CRAB criteriaProgression to MMClonal plasma cellsMarrow plasma cellsMM patient outcomePlasma cell malignancyAggressive diagnostic strategyInternational Classification of Diseases (ICD)-9/10 codesCRAB symptomsPositive detection rateMultiple sclerosis presenting with paroxysmal symptoms: Patients at the limitations of current diagnostic criteria
Heward K, Roy-Hewitson C, Solomon A. Multiple sclerosis presenting with paroxysmal symptoms: Patients at the limitations of current diagnostic criteria. Multiple Sclerosis Journal 2024, 30: 1566-1570. PMID: 38751226, DOI: 10.1177/13524585241253513.Peer-Reviewed Original ResearchMS diagnostic criteriaCentral nervous systemMultiple sclerosisDiagnostic criteriaClinically isolated syndromeRelapsing remitting MSParoxysmal neurological symptomsLhermitte's phenomenonOptic neuritisClinical attacksTrigeminal neuralgiaCase seriesNeurological symptomsTonic spasmsPatient presentationParoxysmal symptomsPatientsClinical guidanceNervous systemSyndromeOptimal careSymptomsAnecdotal reportsSclerosisNeuralgiaNational trends and correlates of treatment resistance in major depressive episode and associated suicidal ideation and behaviors among adults in the United States
Rhee T, Bommersbach T, Rosenheck R, Nierenberg A, McIntyre R. National trends and correlates of treatment resistance in major depressive episode and associated suicidal ideation and behaviors among adults in the United States. Journal Of Affective Disorders 2024, 358: 342-349. PMID: 38734245, DOI: 10.1016/j.jad.2024.05.044.Peer-Reviewed Original ResearchTreatment-resistant depressionMajor depressive episodeSuicidal ideationDepressive episodeAverage annual percent changePast-year suicide attemptPast-year suicidal ideationPast-year major depressive episodePrevalence of suicidal ideationSuicide prevention effortsNational Survey of Drug Use and HealthUS adultsSuicide attemptsDrug Use and HealthNon-pharmacological interventionsHigh-risk populationIdeationAnnual percent changeTreatment resistanceNo significant differenceDiagnostic criteriaPreventive servicesAdultsPercent changeSignificant differenceRasmussen’s Encephalitis and Focal Cortical Dysplasia
Vadiparati A, Herlopian A. Rasmussen’s Encephalitis and Focal Cortical Dysplasia. 2024, 241-286. DOI: 10.1007/978-3-031-23828-4_12.Peer-Reviewed Original ResearchOccipital lobe epilepsyRasmussen encephalitisSurgical interventionLobe epilepsyVisual field analysisSurgical decision-making processFocal cortical dysplasiaLeft occipital lobeAnterior thalamic nucleiClinical presentationCortical dysplasiaMultifocal epilepsySurgical techniqueIntractable seizuresOutcome predictorsDeep brain stimulationThalamic nucleiNeuromodulation therapiesDiagnostic criteriaOccipital lobeOccipital lobectomyProgressive natureEpilepsyBrain stimulationPatientsShifting our attention earlier in the multiple sclerosis disease course
Epstein S, Longbrake E. Shifting our attention earlier in the multiple sclerosis disease course. Current Opinion In Neurology 2024, 37: 212-219. PMID: 38546031, DOI: 10.1097/wco.0000000000001268.Peer-Reviewed Original ResearchConceptsRadiologically isolated syndromeDisease courseStages of MSPrompt initiation of therapyDiagnostic criteriaInitiation of therapyMultiple sclerosisHigh-risk patientsClinical diseaseDisease modifying therapy useMS disease courseRandomized controlled trialsImmunomodulatory therapyPrompt initiationClinical outcomesTherapy useDiagnosed patientsMultiple sclerosis disease courseClinical MSHigh riskPatientsControlled trialsPrevent onsetDisease biologyTherapyPoor ovarian response classification systems in the clinical setting – time for an update?
Reig A, Seli E. Poor ovarian response classification systems in the clinical setting – time for an update? Current Opinion In Obstetrics & Gynecology 2024, 36: 192-199. PMID: 38597510, DOI: 10.1097/gco.0000000000000950.Peer-Reviewed Original ResearchConceptsPoor ovarian responseOvarian responsePoor ovarian response definitionDefinition of poor ovarian responseSuccess of assisted reproductive technologiesEra of personalized medicineOvarian reserve markersAssisted reproductive technologyBologna criteriaEuploid embryosReserve markersReproductive technologyClassification systemDiagnostic criteriaPersonalized medicineCounseling toolEffective predictorHepatorenal Syndrome Type 1: Diagnosis and Treatment
Belcher J. Hepatorenal Syndrome Type 1: Diagnosis and Treatment. Advances In Kidney Disease And Health 2024, 31: 100-110. PMID: 38649214, DOI: 10.1053/j.akdh.2023.05.001.Peer-Reviewed Original ResearchConceptsAcute kidney injuryHepatorenal syndromeKidney injuryFunctional acute kidney injuryUrinary biomarkers of kidney injuryAssociated with significant morbidityFractional excretion of sodiumNeutrophil gelatinase-associated lipocalinDiagnostic criteriaBiomarkers of kidney injuryMultiple urinary biomarkersOptimal dosing strategiesExcretion of sodiumPoint-of-care ultrasoundAccurate differential diagnosisAnalog of vasopressinSets of diagnostic criteriaAdvanced cirrhosisAlbumin administrationSignificant morbidityVolume resuscitationTherapeutic optionsDosing strategiesFractional excretionDifferential diagnosisDiagnosis and Treatment of Gambling Addiction
Mestre-Bach G, Potenza M. Diagnosis and Treatment of Gambling Addiction. 2024 DOI: 10.1093/acrefore/9780190264086.013.135.Peer-Reviewed Original ResearchTreatment of gambling addictionPsychiatric disordersPsychiatric concernsGambling addictionPsychological factorsYoung adultsDiagnostic criteriaComplicate treatmentSocietal harmNeurobiologyAddictionNeurochemistryNeuroimagingAdolescentsShameDisordersIncreased considerationLimited screeningTreatmentAdultsAmbivalenceStigmaMultiple Sclerosis Diagnostic Delay and Misdiagnosis
Kaisey M, Solomon A. Multiple Sclerosis Diagnostic Delay and Misdiagnosis. Neurologic Clinics 2024, 42: 1-13. PMID: 37980109, DOI: 10.1016/j.ncl.2023.07.001.Peer-Reviewed Original ResearchConceptsMultiple sclerosis misdiagnosisPatients' clinical outcomesMS diagnostic criteriaMS symptomsClinical outcomesDiagnostic delayDiagnostic challengeDiagnostic criteriaMS misdiagnosisDiagnostic biomarkersAccurate diagnosisIncorrect diagnosisPatientsDiagnosisMisdiagnosisEducational effortsSymptomsArtificial intelligence methods for improved detection of undiagnosed heart failure with preserved ejection fraction
Wu J, Biswas D, Ryan M, Bernstein B, Rizvi M, Fairhurst N, Kaye G, Baral R, Searle T, Melikian N, Sado D, Lüscher T, Grocott‐Mason R, Carr‐White G, Teo J, Dobson R, Bromage D, McDonagh T, Shah A, O'Gallagher K. Artificial intelligence methods for improved detection of undiagnosed heart failure with preserved ejection fraction. European Journal Of Heart Failure 2024, 26: 302-310. PMID: 38152863, DOI: 10.1002/ejhf.3115.Peer-Reviewed Original ResearchConceptsLeft ventricular ejection fractionDiagnosis of HFpEFEuropean Society of CardiologyHeart failureNatural language processingElectronic health recordsEuropean Society of Cardiology criteriaClinical diagnosis of HFEuropean Society of Cardiology diagnostic criteriaDiagnostic criteriaVentricular ejection fractionRetrospective cohort studyDiagnosis of HFSociety of CardiologyClinician-assigned diagnosisConsecutive patientsHFpEF patientsEjection fractionElectronic health record dataAcute cardiovascular eventsExpert clinical reviewNatural language processing methodsNatural language processing pipelineHFpEFCardiovascular events
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply